Skip to main content
Clinical Trials/ACTRN12610000275066
ACTRN12610000275066
Recruiting
未知

Among patients with cervical dystonia, does treating with transcranial magnetic stimulation in addition to botulinum toxin treatment compared with botulinum toxin alone, give additional benefit and improve quality of life

Monash Medical Centre0 sites32 target enrollmentApril 6, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Cervical Dystonia
Sponsor
Monash Medical Centre
Enrollment
32
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 6, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Monash Medical Centre

Eligibility Criteria

Inclusion Criteria

  • Patients are to be recruited from the Botulinum Toxin Outpatient Clinics at the Monash Medical Centre. All consenting patients with clinical diagnosis of rotational cervical dystonia and stable requirements of Botulinum toxin in the previous 6 months will be included

Exclusion Criteria

  • Exclusion criteria will include those patients with intracranial metal objects or pacemakers, seizures or family history of seizures, pregnant women, those with known excessive alcohol use or serious medical conditions

Outcomes

Primary Outcomes

Not specified

Similar Trials